Walgreens Boots Alliance, Inc.

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
15.7 ^USD	-1.32%		+3.63%	-39.87%

06-24	Equity Markets Close Mixed as Investors Await Key Earnings	MT
06-24	Equity Markets Close Mixed as Investors Await Week's Key Earnings	MT

Walgreens Boots Alliance, Inc. acquired an unknown minority stake in Seek Insurance Services for $20 million.

January 15, 2021

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) acquired an unknown minority stake in Seek Insurance Services for $20 million on September 25, 2020. Sidley Austin LLP acted as legal advisor to Walgreens Boots Alliance. Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of an unknown minority stake in Seek Insurance Services on September 25, 2020.

Latest news about Walgreens Boots Alliance, Inc.

Equity Markets Close Mixed as Investors Await Key Earnings	06-24	MT
Equity Markets Close Mixed as Investors Await Week's Key Earnings	06-24	MT
US Equities Markets End Mixed Monday as Traders Await Key Corporate Earnings	06-24	MT
Equity Markets Mixed as Investors Await Week's Key Earnings	06-24	MT
Walgreens Boots Alliance Fiscal Q3 Unlikely to Impact Stock, UBS Says	06-24	MT
Equity Markets Mixed as Investors Await Week's Key Earnings	06-24	MT
UBS Cuts Price Target on Walgreens Boots Alliance to $17 From $22, Maintains Neutral Rating	06-24	MT
Key week for monetary policy	06-24
Futures Mostly Up Pre-Bell as Investors Prepare for Key Inflation Report; Asia Down, Europe Rises	06-24	MT
Barclays Adjusts Price Target on Walgreens Boots Alliance to $15 From $21	06-24	MT
ANALYST RECOMMENDATIONS : Accenture, Walgreens Boots Alliance, Ge Vernova, Pepsico, Britvic...	06-24
Amazon Pharmacy expands $5 monthly subscription to Medicare patients	06-18	RE
CVS Store-Brand Medications Face Quality Concerns and Higher Recall Rates	06-11	MT
Global markets live: ABB, Roche, Microsoft, Apple, Tesla...	06-10
Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue	06-08	CI
Top law firms in US opioid lawsuits to get hundreds of millions in fees	06-07	RE
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation	06-07	DJ
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation -- Update	06-07	DJ
Sector Update: Health Care Stocks Higher Late Afternoon	06-07	MT
Sector Update: Health Care	06-07	MT
Walgreens Shelves Boots IPO Plans, Explores Other Options	06-07	MT
Walgreens Shelves Boots IPO Plans, Explores Other Options	06-07	MT
Walgreens shelves plans for Boots IPO, Bloomberg News reports	06-07	RE
Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says	06-07	MT
Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22	06-06	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Sector

Drug Retailers

Calendar

27/06/2024 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending

March 28, 2024 at 07:59 pm

Walgreens Boots Alliance, Inc. first light at the end of the tunnel?

November 27, 2023 at 03:22 pm

More Strategies

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

15.91 USD

Average target price

21.52 USD

Spread / Average Target

+35.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
WALGREENS BOOTS ALLIANCE, INC.	-39.87%	13.73B
JD HEALTH INTERNATIONAL INC.	-42.20%	9.46B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-21.70%	7.11B
MATSUKIYOCOCOKARA & CO.	-7.79%	5.88B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+78.71%	4.79B
NAHDI MEDICAL COMPANY	-4.09%	4.54B
CLICKS GROUP LIMITED	+3.97%	4.44B
YIFENG PHARMACY CHAIN CO., LTD.	-21.06%	4.35B
WELCIA HOLDINGS CO., LTD.	-16.95%	2.64B
REDCARE PHARMACY NV	-9.04%	2.63B

Other Drug Retailers